Browse Items (6 total)

  • Tags: Psychopharmacology

Post-traumatic stress disorder is a common condition that affects millions of people across the world. Up to date recommendations based on the best available evidence are vital to prevent and treat this debilitating condition. In this issue, we are…

Alarmingly, only 59% of those who have post-traumatic stress disorder (PTSD) respond to SSRIs. Many of the existing treatments, both pharmacological & non-pharmacological, don't directly target trauma memories which lay at the core in the PTSD…

What options are available to mental health providers helping clients with posttraumatic stress disorder (PTSD)? In this paper we review many of the current pharmacological and psychological interventions available to help prevent and treat PTSD with…

EMDR is a recommended treatment for PTSD by the APA, DOD, and other professional bodies, yet many clinicians are unaware of this approach or question its efficacy. With accumulating research documenting the efficiency of EMDR, clinicians may be…

This paper provides a current review of existing evidence-based treatments for posttraumatic stress disorder (PTSD), with a description of psychopharmacologic options, prolonged exposure therapy, cognitive processing therapy, and eye movement…

The following sections consider biologic and cognitive-behavioral perspectives on PTSD and strategies for its treatment. Pharmacologic strategies examined to date have included treatment with beta-adrenergic blockers and alpha-adrenergic agonists,…
Output Formats

atom, dcmes-xml, json, omeka-xml, rss2